Last reviewed · How we verify

NCT06594562

Free Fluid Detection With Telementored eFAST

Recruiting now NA Last updated 16 September 2025
What this trial tests

NA trial testing Telementored eFAST in Hemoperitoneum in 40 participants. Currently enrolling.

Timeline
18 June 2025
Primary endpoint
1 December 2025
1 February 2026

Quick facts

Lead sponsorOslo University Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment40
Start date18 June 2025
Primary completion1 December 2025
Estimated completion1 February 2026
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Oslo University Hospital

Who can join

18 and older, any sex, with Hemoperitoneum or Ascites. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This feasibility study will evaluate the accuracy of telementored eFAST (Extended Focused Assessment with Sonography in Trauma) in detecting abdominal free fluid in patients who have recently undergone liver surgery. The primary goal is to determine how well the remote-guided ultrasound can identify fluid accumulation compared to conventional ultrasound performed by a radiologist. Participants in this study will be examined with ultrasound, supported in real-time by a remote expert, to assess its accuracy and other relevant performance metrics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Oslo University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06594562.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing